diagnosis and management of Diabetes mellitus and DKA

natnaelax2 12 views 31 slides Aug 31, 2025
Slide 1
Slide 1 of 31
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31

About This Presentation

diagnosis and management of Diabetes mellitus and DKA


Slide Content

Diabetes Mellitus in children 2021

Outline Definition Epidemiology Diagnosis Pathophysiology Clinical Presentation Investigations Management

Definition A chronic metabolic disorder characterized by hyperglycemia Caused by deficiency of insulin or its action Manifested by abnormal metabolism of carbohydrates, protein and fat

Epidemiology Diabetes is the most common endocrine problem Is a major health hazard worldwide. Incidence is alarmingly increasing worldwide Incidence of childhood diabetes range between 3=50/100000

Etiological classification of Diabetes mellitus Type1 diabetes Beta cell destruction Immune mediated Type2 diabetes Insulin resistance Other types MODY Endocrinopathies: Cushing disease Drug or Chemical induced: Glucocorticoids Infections: CMV Genetic : Down’s syndromes Neonatal diabetes mellitus : transient, permanent

Type 1 Diabetes: Etiology Autoimmune Genetic factors Autoimmune factors Environmental factors

Genetic factors Evidence of genetics is shown in Familial clustering High concordance rate in twins 30% for identical twins 85% NT1DM don’t have family history Specific genetic markers Increased frequency of certain histocompatibility antigens i.e. HLAs DR3 & DR4 Higher incidence with genetic syndromes or chromosomal defects

Auto immune Factors Circulating antibodies against beta cell and insulin Immunofluorescent antibodies and lymphocyte infiltration around islet cells Evidence of immune system activation: circulating immune complexes with high IgA and low interferon levels. Association with other autoimmune diseases.

Environmental Factors Seasonal variation Suspicion of environmental agents causing disease which is confirmed by case control experimental animal studies.

Environmental SUSPECTS Viruses Coxaskie B MUMPS RUBELLA REO VIRUSES Nutrition and dietary factors cow’s milk protein Contaminated sea food

Other modifying factors The counter regulatory factors Glucagon Cortisol Catecholamines Thyroxin GH and somatostatin Sex hormones EMOTIONAL STRESS

Pathophysiology The main functions of insulin Reduce blood glucose by: inhibiting glycolysis Inhibiting gluconeogenesis Increasing glucose uptake by cells 2.Inhibiting fat breakdown 3.Inhibiting protein breakdown

Insulin deficiency will lead to: Hyperglycemia: increase glucose` -osmotic diuresis-polyuria-dehydration-Compensatory polydipsia Proteolysis- wt loss-polyphagia Lipolysis: increased fatty acids and accumulation of Acetyl Co-A-Liver-Ketone bodies-ketonemia-ketonuria and metabolic acidosis

Clinical presentation Peak age 5-7 puberty Classical symptom triad: Polyuria, polydipsia weight loss DKA Accidental diagnosis

Diagnosis RBS >200mg/dl /11mmol with poly symptoms FBS>126mg/dl HBA1C Target <7.5{58mmol/ml Urine: glucosuria or ketonuria if DKA Remember acute infections in non diabetic children may cause hyperglycemia with out ketosis *starvation can cause ketosis

Natural history Diagnosis and initiation of insulin Period of metab olic recovery Honeymoon phase State of total insulin dependency

Complications of diabetes Acute/immediate DKA Hypoglycemia Chronic/late Microvascular Retinopathy Nephropathy Neuropathy Macrovascular Ischaemic heart disease and stroke

1.Hypoglycemia Symptoms related to sympathetic discharge sweating, tremulousness and hunger More severe symptoms related to glucose deprivation to the CNS

2. Diabetic Ketoacidosis hyperglycemia BG>200mg/dl (>11mmol/l Ketonemia and ketonuria>or=2+ Metabolic acidosis (pH<7.3,Bicarbonaate <15meq/l Severity of DKA By degree of acidosis Mild : venous PH<7.3 or Serum Bicarbonate< 15mmol/l Moderate : <7.2 , HCO3<10mm0l/l Severe: < 7.1 , HCO3<5mmol/l

Diabetic Ketoacidosis Assessment History known diabetic: Omission, Infection Suspected diabetic: poly symptoms, wt loss, abdominal pain ,vomiting B. Examination: assess for dehydration, kussmaul’s breathing ,fruity breath ,mental status and current wt

DKA C. Laboratory tests Check blood glucose, blood gas, electrolytes Urinalysis for glucose and ketones

Management of DKA Goals of treatment of DKA Correct dehydration Correct acidosis and reverse ketosis Restore blood glucose to near normal Monitor for complications of DKA and its treatment Identify and treat any precipitating event

Management of DKA Fluid Assume 5-10% dehydration dictated by clinical examination Give 10-20meq/kg bolus of N/S or Rl over 1hr Then replace the remaining deficit and maintenance fluid requirement over 36-48hrs Add 5% glucose to the fluid when BG drops to 250-300mg/dl

DKA management B. Insulin Started after the initial bolus is completed if hemodynamically stable IV insulin is preferred 0.1/kg per hour insulin as continuous drip C. Glucose Measure hourly Rate of fall should not exceed 80-100mg/dl/ hr If>100mg/dl/ hr add 10%glucose As BG approaches 250-300mg/dl, add D5to IVF regardless of rate of fall

D. Electrolytes Potassium Risk of hypokalemia during DKA management 20-40meq/l of k+ after patient has passed urine check 2hrly 2. Sodium 0.9% or ½ NS for rehydration serum Na+ rises as BG falls 3. Bicarbonate rarely used for severe DKA with caution

Treatment goals Prevent death and alleviate symptoms Achieve biochemical control Maintain growth and development Prevent acute complications Prevent late onset complications

Management Elements Insulin replacement 0.75-1u/kg daily a. Divided between short acting regular insulin &intermediate acting, Lente in a 1:3 proportion 2/3 am/ 1/3 pm b. Multiple 3 to 4 doses of regular insulin before meals supplemented with once or twice daily intermediate insulin source Recombinant human insulin: less immunogenic

Management Elements 2. Diet A meal plan that promotes normal growth and wt gain Avoid simple sugars encourage fibers and complex carbohydrates 55-30-15, Carb-Fat-Protein Equivalent calories 20-10-20-10-30-10 Must be eaten on time

3.Exercise regular exercise Should be encouraged Caution for hypoglycemia No restriction on individual or organized athletic programs 4. Education Techniques of insulin injection Home BG monitoring Recognition and treatment of hypoglycemia Recognition of DKA Meal plan Sick day management

Management elements 5. Psychological support and Counseling of patient and family 6. Medical follow up Regular follow up Every 3-4 months

Thank you!! THANK YOU!!
Tags